Upperton honoured at Sunday Times 100 Fastest Growing Companies Ceremony

Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO), was recognised at the Sunday Times 100 Fastest Growing Companies awards event on Wednesday, 18th September at the prestigious British Museum in London. The event celebrated Britain’s top 100 fastest-growing companies, with Upperton making its mark at Number 73 on the 2024 list.

Upperton’s Chief Executive Officer, Nikki Whitfield, and Chief Scientific Officer and Founder, Richard Johnson, represented the company at the ceremony.

Reflecting on the honour, Nikki Whitfield commented:

“It is fantastic to attend this event at such an inspiring venue along with our peers, as we celebrate our continued successes over the years.”

This milestone recognition follows a year of significant growth for Upperton, marked by the construction of its state-of-the-art development and manufacturing facility, Trent Gateway. With MHRA Approval achieved and the finalisation of a new sterile fill/finish facility underway, Upperton is further enhancing its offering to customers in need of flexible and nimble CDMO solutions.

Highlighting the importance of the recognition, Nikki adds: 

“Being featured in the 2024 edition of The Sunday Times 100 is a significant professional endorsement, and being at this event alongside other great companies and entrepreneurs is a testament to our amazing team’s hard work and dedication.”

This year also marks a major milestone for Upperton, as the company celebrates its 25th anniversary. Reflecting on the journey, Richard Johnson, Chief Scientific Officer and Founder, said: 

“Being able to celebrate at this great venue, knowing that Upperton continues to grow at phenomenal speed, is incredible. The values that Upperton was founded on—doing good science and putting the needs of our customers first—remain at the top of our agenda twenty-five years later.”

As Upperton continues to expand, the company remains committed to its core values and to delivering cutting-edge solutions for drug formulation and manufacturing.